Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 24,576 shares, a drop of 77.7% from the April 30th total of 110,046 shares. Based on an average trading volume of 31,239 shares, the short-interest ratio is presently 0.8 days. Approximately 0.1% of the company’s shares are short sold.
Basel Medical Group Stock Up 4.8%
BMGL stock traded up $0.03 during trading on Friday, hitting $0.61. 9,260 shares of the company’s stock traded hands, compared to its average volume of 31,977. Basel Medical Group has a 52 week low of $0.49 and a 52 week high of $9.40. The stock has a fifty day moving average price of $0.63 and a two-hundred day moving average price of $0.73.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings upgraded shares of Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Marex Group plc bought a new stake in shares of Basel Medical Group in the 2nd quarter worth $25,000. Virtu Financial LLC boosted its stake in shares of Basel Medical Group by 108.8% during the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after acquiring an additional 17,608 shares in the last quarter. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Basel Medical Group during the 3rd quarter worth $40,000. Finally, Citadel Advisors LLC bought a new stake in shares of Basel Medical Group during the 3rd quarter worth $169,000.
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
Featured Articles
- Five stocks we like better than Basel Medical Group
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
